Insufficient/inadequate category in breast cytology: Are the standardized guidelines of rapid on‐site evaluation available to reduce its rate?. Issue 5 (18th March 2023)

• Record Type: Journal Article
• Authors: Bharti, Jyotsna Naresh; Nigam, Jitendra Singh; Rath, Ashutosh; Pradeep, Immanuel
• Is Part Of: Diagnostic cytopathology. Volume 51:Issue 5(2023)
• Page Start: 321
• Page End: 324
• Publication Date: 2023-03-18
• Subjects: breast -- cytopathology -- FNAB -- ROSE; Cytodiagnosis -- Periodicals; Pathology, Cellular -- Periodicals; Cytology -- Periodicals; 616.07582
• DOI: 10.1002/dc.25126
• Languages: English
• ISSNs: 8755-1039

Abstract

Abstract: In 2017, the International Academy of Cytology announced a five‐tier reporting system for breast fine‐needle aspiration biopsy (FNAB) cytopathology. We observed the insufficient/inadequate cases rate varied from 2.05% to 39.89%, with a risk of malignancy varying from 0% to 60.87%. This wide range of variation poses a significant number of patients at risk due to delay in management. Some authors describe rapid on‐site evaluation (ROSE) as a tool to reduce its rate. In this preliminary review, we also observed that there were no uniform guidelines available for ROSE to reduce the insufficient/inadequate category rate. We expect that cytopathologists will construct some uniform guidelines for ROSE in the future, which may help to reduce the rate of category 1.